Soluble recombinant human metapneumovirus G protein is immunogenic but not protective

Vaccine

Volumn 28, Issue 25, 2010, Pages 4145-4152

  Ryder, Alex B ^a   Tollefson, Sharon J ^b   Podsiad, Amy B ^b   Johnson, Joyce E ^b   Williams, John V ^b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b Department of Pediatrics ^*  (United States)

Author keywords

Glycoprotein; Metapneumovirus; Paramyxovirus; Vaccine

Indexed keywords

NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN; VIRUS GLYCOPROTEIN G;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; GUINEA PIG; HUMAN METAPNEUMOVIRUS; IMMUNIZATION; IMMUNOGENICITY; METAPNEUMOVIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CYTOKINES; GLYCOPROTEINS; GLYCOSYLATION; GUINEA PIGS; LUNG; METAPNEUMOVIRUS; PARAMYXOVIRIDAE INFECTIONS; RATS; RECOMBINANT PROTEINS; VACCINATION; VIRAL PROTEINS;

EID: 77952582621     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.04.007     Document Type: Article

References (44)

1. Williams J.V., Wang C.K., Yang C.F., Tollefson S.J., House F.S., Heck J.M., et al. The role of human metapneumovirus in upper respiratory tract infections in children: a 20-year experience. J Infect Dis 193 February (3) (2006) 387-395
2. Williams J.V., Harris P.A., Tollefson S.J., Halburnt-Rush L.L., Pingsterhaus J.M., Edwards K.M., et al. Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children. N Engl J Med 350 January (5) (2004) 443-450
3. van den Hoogen B.G., van Doornum G.J., Fockens J.C., Cornelissen J.J., Beyer W.E., de Groot R., et al. Prevalence and clinical symptoms of human metapneumovirus infection in hospitalized patients. J Infect Dis 188 November (10) (2003) 1571-1577
4. van den Hoogen B.G., de Jong J.C., Groen J., Kuiken T., de Groot R., Fouchier R.A., et al. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med 7 June (6) (2001) 719-724
5. Sloots T.P., Mackay I.M., Bialasiewicz S., Jacob K.C., McQueen E., Harnett G.B., et al. Human metapneumovirus, Australia, 2001-2004. Emerg Infect Dis 12 August (8) (2006) 1263-1266
6. Peiris J.S., Tang W.H., Chan K.H., Khong P.L., Guan Y., Lau Y.L., et al. Children with respiratory disease associated with metapneumovirus in Hong Kong. Emerg Infect Dis 9 June (6) (2003) 628-633
7. Mullins J.A., Erdman D.D., Weinberg G.A., Edwards K., Hall C.B., Walker F.J., et al. Human metapneumovirus infection among children hospitalized with acute respiratory illness. Emerg Infect Dis 10 April (4) (2004) 700-705
8. Martinello R.A., Esper F., Weibel C., Ferguson D., Landry M.L., and Kahn J.S. Human metapneumovirus and exacerbations of chronic obstructive pulmonary disease. J Infect 53 October (4) (2006) 248-254
9. Falsey A.R., Erdman D., Anderson L.J., and Walsh E.E. Human metapneumovirus infections in young and elderly adults. J Infect Dis 187 March (5) (2003) 785-790
10. Esper F., Martinello R.A., Boucher D., Weibel C., Ferguson D., Landry M.L., et al. A 1-year experience with human metapneumovirus in children aged <5 years. J Infect Dis 189 April (8) (2004) 1388-1396
11. Boivin G., De Serres G., Cote S., Gilca R., Abed Y., Rochette L., et al. Human metapneumovirus infections in hospitalized children. Emerg Infect Dis 9 June (6) (2003) 634-640
12. McAdam A.J., Hasenbein M.E., Feldman H.A., Cole S.E., Offermann J.T., Riley A.M., et al. Human metapneumovirus in children tested at a tertiary-care hospital. J Infect Dis 190 July (1) (2004) 20-26
13. van den Hoogen B.G., Bestebroer T.M., Osterhaus A.D., and Fouchier R.A. Analysis of the genomic sequence of a human metapneumovirus. Virology 295 March (1) (2002) 119-132
14. Englund J.A., Boeckh M., Kuypers J., Nichols W.G., Hackman R.C., Morrow R.A., et al. Brief communication: fatal human metapneumovirus infection in stem-cell transplant recipients. Ann Intern Med 144 March (5) (2006) 344-349
15. Larcher C., Geltner C., Fischer H., Nachbaur D., Muller L.C., and Huemer H.P. Human metapneumovirus infection in lung transplant recipients: clinical presentation and epidemiology. J Heart Lung Transplant 24 11 (2005 Nov) 1891-1901
16. Boivin G., De Serres G., Hamelin M.E., Cote S., Argouin M., Tremblay G., et al. An outbreak of severe respiratory tract infection due to human metapneumovirus in a long-term care facility. Clin Infect Dis 44 May (9) (2007) 1152-1158
17. Hamelin M.E., Cote S., Laforge J., Lampron N., Bourbeau J., Weiss K., et al. Human metapneumovirus infection in adults with community-acquired pneumonia and exacerbation of chronic obstructive pulmonary disease. Clin Infect Dis 41 August (4) (2005) 498-502
18. van den Hoogen B.G. Respiratory tract infection due to human metapneumovirus among elderly patients. Clin Infect Dis 44 May (9) (2007) 1159-1160
19. Vicente D., Montes M., Cilla G., and Perez-Trallero E. Human metapneumovirus and chronic obstructive pulmonary disease. Emerg Infect Dis 10 July (7) (2004) 1338-1339
20. Williams J.V., Crowe Jr. J.E., Enriquez R., Minton P., Peebles Jr. R.S., Hamilton R.G., et al. Human metapneumovirus infection plays an etiologic role in acute asthma exacerbations requiring hospitalization in adults. J Infect Dis 192 October (7) (2005) 1149-1153
21. Williams J.V., Martino R., Rabella N., Otegui M., Parody R., Heck J.M., et al. A prospective study comparing human metapneumovirus with other respiratory viruses in adults with hematologic malignancies and respiratory tract infections. J Infect Dis 192 September (6) (2005) 1061-1065
22. Cseke G., Wright D.W., Tollefson S.J., Johnson J.E., Crowe Jr. J.E., and Williams J.V. Human metapneumovirus fusion protein vaccines that are immunogenic and protective in cotton rats. J Virol 81 January (2) (2007) 698-707
23. Herfst S., de Graaf M., Schrauwen E.J., Ulbrandt N.D., Barnes A.S., Senthil K., et al. Immunization of Syrian golden hamsters with F subunit vaccine of human metapneumovirus induces protection against challenge with homologous or heterologous strains. J Gen Virol 88 October (Pt 10) (2007) 2702-2709
24. Skiadopoulos M.H., Biacchesi S., Buchholz U.J., Riggs J.M., Surman S.R., Amaro-Carambot E., et al. The two major human metapneumovirus genetic lineages are highly related antigenically, and the fusion (F) protein is a major contributor to this antigenic relatedness. J Virol 78 July (13) (2004) 6927-6937
25. Tang R.S., Mahmood K., Macphail M., Guzzetta J.M., Haller A.A., Liu H., et al. A host-range restricted parainfluenza virus type 3 (PIV3) expressing the human metapneumovirus (hMPV) fusion protein elicits protective immunity in African green monkeys. Vaccine 23 February (14) (2005) 1657-1667
26. Biacchesi S., Pham Q.N., Skiadopoulos M.H., Murphy B.R., Collins P.L., and Buchholz U.J. Infection of nonhuman primates with recombinant human metapneumovirus lacking the SH, G, or M2-2 protein categorizes each as a nonessential accessory protein and identifies vaccine candidates. J Virol 79 October (19) (2005) 12608-12613
27. Biacchesi S., Skiadopoulos M.H., Yang L., Lamirande E.W., Tran K.C., Murphy B.R., et al. Recombinant human Metapneumovirus lacking the small hydrophobic SH and/or attachment G glycoprotein: deletion of G yields a promising vaccine candidate. J Virol 78 December (23) (2004) 12877-12887
28. Liu L., Bastien N., and Li Y. Intracellular processing, glycosylation, and cell surface expression of human metapneumovirus attachment glycoprotein. J Virol October (2007)
29. Cseke G., Maginnis M.S., Cox R.G., Tollefson S.J., Podsiad A.B., Wright D.W., et al. Integrin {alpha}v{beta}1 promotes infection by human metapneumovirus. Proc Natl Acad Sci USA January (2009)
30. Bao X., Liu T., Shan Y., Li K., Garofalo R.P., and Casola A. Human metapneumovirus glycoprotein G inhibits innate immune responses. PLoS Pathog 4 5 (2008) e1000077
31. Tripp R.A., Jones L.P., Haynes L.M., Zheng H., Murphy P.M., and Anderson L.J. CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein. Nat Immunol 2 August (8) (2001) 732-738
32. Williams J.V., Tollefson S.J., Johnson J.E., and Crowe Jr. J.E. The cotton rat (Sigmodon hispidus) is a permissive small animal model of human metapneumovirus infection, pathogenesis, and protective immunity. J Virol 79 September (17) (2005) 10944-10951
33. van den Hoogen B.G., Herfst S., Sprong L., Cane P.A., Forleo-Neto E., de Swart R.L., et al. Antigenic and genetic variability of human metapneumoviruses. Emerg Infect Dis 10 April (4) (2004) 658-666
34. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72 May (1976) 248-254
35. Spector T. Refinement of the coomassie blue method of protein quantitation. A simple and linear spectrophotometric assay for less than or equal to 0. 5 to 50 microgram of protein. Anal Biochem 86 May (1) (1978) 142-146
36. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25 December (4) (2001) 402-408
37. Skiadopoulos M.H., Biacchesi S., Buchholz U.J., Amaro-Carambot E., Surman S.R., Collins P.L., et al. Individual contributions of the human metapneumovirus F, G, and SH surface glycoproteins to the induction of neutralizing antibodies and protective immunity. Virology 345 February (2) (2006) 492-501
38. Williams J.V., Chen Z., Cseke G., Wright D.W., Keefer C.J., Tollefson S.J., et al. A recombinant human monoclonal antibody to human metapneumovirus fusion protein that neutralizes virus in vitro and is effective therapeutically in vivo. J Virol 81 August (15) (2007) 8315-8324
39. Beck I., Gerlach H., Burkhardt E., and Kaleta E.F. Investigation of several selected adjuvants regarding their efficacy and side effects for the production of a vaccine for parakeets to prevent a disease caused by a paramyxovirus type 3. Vaccine 21 February (9-10) (2003) 1006-1022
40. Berhanu A., Wilson R.L., Kirkwood-Watts D.L., King D.S., Warren T.K., Lund S.A., et al. Vaccination of BALB/c mice with Escherichia coli-expressed vaccinia virus proteins A27L, B5R, and D8L protects mice from lethal vaccinia virus challenge. J Virol 82 April (7) (2008) 3517-3529
41. Mok H., Tollefson S.J., Podsiad A.B., Shepherd B.E., Polosukhin V.V., Johnston R.E., et al. An alphavirus replicon-based human metapneumovirus vaccine is immunogenic and protective in mice and cotton rats. J Virol 82 November (22) (2008) 11410-11418
42. Padhi A., and Verghese B. Positive natural selection in the evolution of human metapneumovirus attachment glycoprotein. Virus Res October (2007)
43. Melendi G.A., Zavala F., Buchholz U.J., Boivin G., Collins P.L., Kleeberger S.R., et al. Mapping and characterization of the primary and anamnestic H-2(d)-restricted cytotoxic T-lymphocyte response in mice against human metapneumovirus. J Virol 81 October (20) (2007) 11461-11467
44. Herd K.A., Mahalingam S., Mackay I.M., Nissen M., Sloots T.P., and Tindle R.W. Cytotoxic T-lymphocyte epitope vaccination protects against human metapneumovirus infection and disease in mice. J Virol 80 February (4) (2006) 2034-2044